Altimmune (ALT) Revenue (2010 - 2025)
Altimmune (ALT) posted quarterly Revenue of $26000.0 for Q4 2025, up 420.0% year-over-year from $5000.0 in Q4 2024, and up 420.0% quarter-over-quarter from $5000.0 in Q3 2025.
Altimmune (ALT) Revenue (2010 - 2025) Analysis & Trends
Altimmune (ALT) has reported Revenue for 16 consecutive years, with $26000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Revenue rose 420.0% year-over-year to $26000.0; the TTM figure through Dec 2025 stood at $41000.0 (up 105.0% YoY), while the FY2025 annual figure was $41000.0, up 105.0% from the prior year.
- Revenue advanced to $26000.0 in Q4 2025 per ALT's latest filing, from $5000.0 in the prior quarter.
- Across five years, Revenue topped out at $3.3 million in Q4 2021 and bottomed at $2000.0 in Q3 2022.
- Historically, Revenue has averaged $248250.0 across 5 years, with a median of $14500.0 in 2022.
- Annual changes were most pronounced in 2022 — Revenue tumbled 99.21% — and 2023, when it jumped 18000.0%.
- Altimmune's Revenue stood at $3.3 million in 2021, then sank by 99.21% to $26000.0 in 2022, then surged by 42.31% to $37000.0 in 2023, then slumped by 86.49% to $5000.0 in 2024, then soared by 420.0% to $26000.0 in 2025.
- Business Quant data shows ALT's Revenue at $26000.0 in Q4 2025, $5000.0 in Q3 2025, and $5000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Altimmune | 571.75 Mn | 571.75 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 5,000.00 |
| Sep 30, 2024 | 5,000.00 |
| Jun 30, 2024 | 5,000.00 |
| Mar 31, 2024 | 5,000.00 |
| Dec 31, 2023 | 37,000.00 |
| Sep 30, 2023 | 362,000.00 |
| Jun 30, 2023 | 6,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 26,000.00 |
| Sep 30, 2022 | 2,000.00 |
| Jun 30, 2022 | 8,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | 3.28 Mn |
| Sep 30, 2021 | 158,000.00 |
| Jun 30, 2021 | 137,000.00 |
| Mar 31, 2021 | 838,000.00 |